Home

MAPRx urges Congress and CMS to establish comprehensive obesity coverage in Medicare Part D through a one pager.

Highlights include:

• Treat and Reduce Obesity Act: Bipartisan, bicameral legislation to establish anti-obesity medication coverage through Medicare Part D
• CMS Guidance: to establish AOM coverage thorough revised Part D plan guidance and/or regulation

Earlier today the MAPRx Coalition released the Issue Brief: Minimizing Affordability Challenges and Beneficiary Confusion. Linked HERE.

Highlights of the Issue Brief:

• Key finalized provisions from Part 1 Guidance
• Key proposed provisions from Part 2 Guidance
• Key insights from coalition members and the focus group
• Educational outreach checklist

The Annual Open Enrollment for Medicare prescription drug coverage (Part D) is October 15, 2023 – December 7, 2023 for coverage beginning January 1, 2024. Plans make changes to benefits and costs, and there are also new plans in many areas of the country. Changes to the Part D benefit as a whole may also impact how beneficiaries move through... Read more

Earlier today, the MAPRx Coalition submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the implementation of the Medicare Prescription Payment Plan program set to take effect for Contract Year (CY) 2025 per the Memorandum Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of... Read more